We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
103 hedge funds and large institutions have $308M invested in Lexicon Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 23 increasing their positions, 28 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
9% less call options, than puts
Call options by funds: $1.29M | Put options by funds: $1.43M
2.64% less ownership
Funds ownership: 99.02% → 96.38% (-2.6%)
6% less funds holding
Funds holding: 109 → 103 (-6)
18% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 28
22% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 23
53% less capital invested
Capital invested by funds: $662M → $308M (-$354M)
Holders
103
Holders Change
-6
Holders Change %
-5.5%
% of All Funds
2.26%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
18
Increased
23
Reduced
28
Closed
23
Calls
$1.29M
Puts
$1.43M
Net Calls
-$135K
Net Calls Change
+$1.79M
Top Buyers
| 1 |
BC
Boxer Capital
San Diego,
California
|
+$7.74M |
| 2 |
Millennium Management
New York
|
+$3.67M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.64M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.51M |
| 5 |
Morgan Stanley
New York
|
+$865K |
Top Sellers
| 1 |
First Manhattan
New York
|
-$18.6M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$9.31M |
| 3 |
ClearBridge Investments
New York
|
-$9.2M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.65M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.25M |
